Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

AI FINDS “AMAZING” NEW ANTIBIOTIC

by Bennett Davis
Using a machine learning program, artificial intelligence software at MIT has designed a new antibiotic able to kill dozens of bacteria, including some that defeat all other known antibiotics.
The developers called the find “amazing” and believe it ranks among the most important antibiotics ever discovered because of its range of effectiveness.
The new drug is named Halicin; “-icin” is a common ending for antibiotic names and “Hal” salutes the computer in the film 2001: A Space Odyssey.
The researchers designed their computer model to look for chemical features that make molecules effective at killing E. coli bacteria. To do so, they showed the model about 2,500 compounds, including 1,700 FDA-approved drugs and a set of 800 natural remedies with diverse structures and a wide range of bioactivities.
The resulting machine learning project, which can screen more than a hundred million chemical compounds in a matter of days, was designed specifically to imagine potential antibiotics that can kill bacteria using different mechanisms than those of existing anti-bacterial drugs. Halicin was the result.
In tests, E. coli bacteria didn’t become resistant to Halicin within a 30-day treatment period in mice. In contrast, in no more than three days, the bacteria developed a defense against ciprofloxacin, a common antibiotic used to treat a range of infections.
Halicin also was found to do no damage to healthy tissue or to beneficial bacteria that live in the human digestive tract.
TRENDPOST: Antibiotic resistance is a high-priority health emergency as bugs that once succumbed to antibiotic treatments no longer do. Halicin is the first of a new generation of antibiotics designed and tested by computer that can defeat resistant bacteria and will replace older drugs as human clinical trials are completed.
AI programs such as this one also can be refined to custom-design therapeutic compounds for individuals based on their unique body chemistry.

Comments are closed.